Published in

Elsevier, Annals of Oncology, (27), p. vi275, 2016

DOI: 10.1093/annonc/mdw373.20

Elsevier, European Journal of Cancer, (69), p. S45-S46

DOI: 10.1016/s0959-8049(16)32720-4

Links

Tools

Export citation

Search in Google Scholar

Clinical significance of early circulating tumor cells (CTC) changes, analyzed by AdnaTest, in patients (pts) receiving first-line methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy (CT) for metastatic urothelial cancer (UC)

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO